Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2015, Article ID 817592, 3 pages
http://dx.doi.org/10.1155/2015/817592
Case Report

Dramatic Improvement of Subcutaneous Calcinosis by Intermittent, High-Dose Etidronate plus Cimetidine in a Patient with Juvenile Dermatomyositis

1Department of Rheumatology, Tokai University Hachioji Hospital, 1838 Ishikawamachi, Hachioji 192-0032, Japan
2Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Japan

Received 18 June 2015; Revised 2 November 2015; Accepted 2 November 2015

Academic Editor: Jamal Mikdashi

Copyright © 2015 Takayuki Wakabayashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Boulman, G. Slobodin, M. Rozenbaum, and I. Rosner, “Calcinosis in rheumatic diseases,” Seminars in Arthritis and Rheumatism, vol. 34, no. 6, pp. 805–812, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. L. Bowyer, C. E. Blane, D. B. Sullivan, and J. T. Cassidy, “Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification,” The Journal of Pediatrics, vol. 103, no. 6, pp. 882–888, 1983. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. E. Sallum, F. C. M. M. Pivato, U. Doria-Filho et al., “Risk factors associated with calcinosis of juvenile dermatomyositis,” Jornal de Pediatria, vol. 84, no. 1, pp. 68–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Sanner, J.-T. Gran, I. Sjaastad, and B. Flatø, “Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset,” Rheumatology, vol. 48, no. 12, pp. 1541–1547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Mukamel, G. Horev, and M. Mimouni, “New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment,” Journal of Pediatrics, vol. 138, no. 5, pp. 763–766, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Nakamura, A. Kawakami, H. Ida, E. Ejima, T. Origuchi, and K. Eguchi, “Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis,” Journal of Rheumatology, vol. 33, no. 8, pp. 1691–1693, 2006. View at Google Scholar · View at Scopus
  7. E. Skuterud, O. A. Sydnes, and T. K. Haavik, “Calcinosis in dermatomyositis treated with probenecid,” Scandinavian Journal of Rheumatology, vol. 10, no. 2, pp. 92–94, 1981. View at Publisher · View at Google Scholar · View at Scopus
  8. W.-J. Wang, W.-L. Lo, and C.-K. Wong, “Calcinosis cutis in juvenile dermatomyositis: remarkable response to aluminium hydroxide therapy,” Archives of Dermatology, vol. 124, no. 11, pp. 1721–1722, 1988. View at Publisher · View at Google Scholar · View at Scopus
  9. G. M. A. Palmieri, J. I. Sebes, J. A. Aelion et al., “Treatment of calcinosis with diltiazem,” Arthritis and Rheumatism, vol. 38, no. 11, pp. 1646–1654, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. M. B. Oliveri, R. Palermo, C. Mautalen, and O. Hübscher, “Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis,” The Journal of Rheumatology, vol. 23, no. 12, pp. 2152–2155, 1996. View at Google Scholar · View at Scopus
  11. M.-C. Yang, J.-H. Lee, Y.-H. Yang, and B.-L. Chiang, “Improvement of juvenile dermatomyositis with calcinosis universalis after treatment with intravenous immunoglobulin,” International Journal of Rheumatic Diseases, vol. 11, no. 1, pp. 77–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Riley, L. J. Mccann, S. M. Maillard, P. Woo, K. J. Murray, and C. A. Pilkington, “Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis,” Rheumatology, vol. 47, no. 6, pp. 877–880, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. F. Rabens and J. E. Bethune, “Disodium etidronate therapy for dystrophic cutaneous calcification,” Archives of Dermatology, vol. 111, no. 3, pp. 357–361, 1975. View at Publisher · View at Google Scholar · View at Scopus
  14. A. L. Metzger, F. R. Singer, R. Bluestone, and C. M. Pearson, “Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma,” The New England Journal of Medicine, vol. 291, no. 24, pp. 1294–1296, 1974. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Slimani, A. Abdessemed, A. Haddouche, and A. Ladjouze-Rezig, “Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate,” Joint Bone Spine, vol. 77, no. 1, pp. 70–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Martillotti, D. Moote, and L. Zemel, “Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis,” Pediatric Radiology, vol. 44, no. 1, pp. 115–118, 2014. View at Publisher · View at Google Scholar · View at Scopus